At what enterprise value was ADVANCION (ANGUS CHEMICAL) acquired in 2020?

During the acquisition of ADVANCION (ANGUS CHEMICAL) by ARDIAN in 2020, the company was valued at an estimated revenue multiple of 5x - 12x. The transaction's Enterprise Value is estimated to be in the range of 1b - 4b USD. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Industry & Manufacturing industry currently tracks an average EBITDA multiple of 11.2x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of ADVANCION (ANGUS CHEMICAL) when it was acquired by ARDIAN?

The estimated EV/EBITDA multiple for ADVANCION (ANGUS CHEMICAL) is in the range of 15x - 25x. For comparison, the Industry & Manufacturing sector currently shows an average EBITDA multiple of 11.2x. Join our community for free to access full valuation data and industry trends.

When was ADVANCION (ANGUS CHEMICAL) acquired by ARDIAN?

ADVANCION (ANGUS CHEMICAL) was acquired by ARDIAN in 2020.

What was the revenue of ADVANCION (ANGUS CHEMICAL) at the time of the deal?

The revenue of ADVANCION (ANGUS CHEMICAL) at the time of the deal is estimated to be in the range of 250M - 500M USD. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of ADVANCION (ANGUS CHEMICAL) during the acquisition?

ADVANCION (ANGUS CHEMICAL)'s EBITDA is estimated to be in the range of 100M - 200M USD. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the ADVANCION (ANGUS CHEMICAL) acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the ADVANCION (ANGUS CHEMICAL) deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://capitalfinance.lesechos.fr/deals/international/ardian-sadjuge-50-dangus-chemical-valorise-225-md-1255877

← DATABASE

Home Database Industry & ManufacturingADVANCION (ANGUS CHEMICAL)

10/2020

ADVANCION (ANGUS CHEMICAL) acquired by ARDIAN

UNITED STATES Chemicals & Materials / Specialty Chemicals EV 1b - 4b USD

Context

Ardian, the global private investment house, acquired a 50% ownership stake in Angus Chemical Company from Golden Gate Capital. The investment was driven by Angus's indispensable position within the global Life Sciences value chain. During the pandemic, Angus's nitroalkane derivatives became vital components for the manufacture of diagnostic kits, antibody treatments, vaccines, and high-alcohol hand sanitizers. Ardian's strategy is to use Angus as a platform for a global "Buy-and-Build" strategy, specifically targeting additional specialty chemical companies in Europe and Asia to further diversify its life sciences and personal care portfolio.

ADVANCION (ANGUS CHEMICAL), which reported an EBITDA margin of LOGIN in 2020, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Industry & Manufacturing sector (11.2x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Industry & Manufacturing market trends

Target

Angus is the world s only chemical company dedicated to the manufacture and distribution of nitroalkanes and their derivatives. Its specialty additives and intermediates are critical "mission-critical" components in life sciences, personal care, and Corporate applications. Key products include TRIS AMINO™ tromethamine, a vital buffer used in the manufacturing of vaccines and biopharmaceuticals.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (USD)

Year

Rev

EBITDA

EBIT

2020

2019

Similar deals in Industry & Manufacturing

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
12/2020	FRANCHI UMBERTO MARMI	INGEGNER GIULIO FAGGIONI CARRARA	ITALY	Chemicals & Materials	The transaction involves the acquisition of a 50% interest in Ingegner Giulio Faggioni Carrara (IGFC) by the listed entity Franchi Umberto Marmi (FUM). A significant feature of the transaction is the strategic reinvestment by the seller, Giulio Vanelli Marmi (GVM), which subscribed to a 29
11/2020	CRODA INTERNATIONAL	IBERCHEM GROUP	SPAIN	Chemicals & Materials	Croda International has acquired Iberchem Group from the French private equity firm Eurazeo. This acquisition provides Croda with an immediate, high-growth platform in the global Fragrances & Flavours (F&F) market
09/2020	CLAYENS GROUP	PSB INDUSTRIES (HEALTHCARE & INDUSTRY)	FRANCE	Chemicals & Materials	This operation represents the first programmatic bolt-on acquisition executed by Clayens NP since its primary sponsor-backed buyout, designed to accelerate the platform’s diversification into highly resilient and high-margin healthcare manufacturing verticals
06/2020	CEREA PARTNERS / BPIFRANCE	AXIUM PACKAGING	FRANCE	Chemicals & Materials	Private equity firm Cerea Partners, utilizing its Cerea Capital II fund, has completed the acquisition of family-owned group Axium through a primary LBO transaction. As part of this deal finalized on June 25, 2020, Bpifrance has joined the consortium to acquire a minority equity stake in the business
03/2020	SPARRING CAPITAL	PURE TRADE WORLDWIDE	FRANCE	Chemicals & Materials	Sparring Capital acquired a majority stake in Pure Trade alongside the management team. The transaction marked the first deployment of the Sparring Capital Fund 2. The partnership was strictly engineered to accelerate Pure Trade’s international expansion—particularly in the United States—and to professionalize the group’s organization while participating in sector consolidation via external growth
03/2020	ALLIANCE ETIQUETTES	5 SEPT ETIQUETTE	FRANCE	Chemicals & Materials	Alliance Etiquettes has completed its eighth external growth operation since 2015 with the acquisition of 100% of the share capital of 5 Sept Etiquette. This strategic transaction significantly reinforces the group's presence in the Southeastern France region (Provence / Rhone Valley), a critical area for premium wine production
02/2020	SOFIMAC REGIONS / ESFIN PARTICIPATIONS	PONCIN METAL	FRANCE	Chemicals & Materials	Poncin Metal underwent a management buyout supported by Sofimac Regions and Esfin Participations. The transaction allowed for a smooth leadership transition while providing the capital needed to pursue an ambitious modernization plan
01/2020	KAMAN CORPORATION	BAL SEAL ENGINEERING	UNITED STATES	Chemicals & Materials	This control transaction represents the full acquisition of Bal Seal Engineering by Kaman Corporation, executing on a defined capital reallocation script following Kaman’s strategic divestiture of its low-margin automation and fluid power distribution units to Littlejohn & Co
01/2020	COBEPA	GERFLOR	FRANCE	Chemicals & Materials	Cobepa S.A. has acquired a majority stake in Gerflor SAS from Intermediate Capital Group (ICG) and other shareholders, including Credit Mutuel Equity. Following the transaction, ICG (which had owned the company since 2011) will retain a significant minority stake
12/2019	GREEN ARROW CAPITAL	POPLAST	ITALY	Chemicals & Materials	Green Arrow Capital has acquired a majority stake in Poplast from Eos Investment Management (which held 86.5%) and minority operating partners. The management team, including Carlo Callegari and Pierangelo Fantoni, has reinvested in the company

REFERENCES

Valuation range: EV 1b - 4b USD

Revenue range: 250M - 500M USD

EBITDA range: 100M - 200M USD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ADVANCION (ANGUS CHEMICAL) by ARDIAN are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Acquirer: ardian